Borosil Scientific Ltd Valuation Shifts Signal Renewed Price Attractiveness

Valuation Metrics Reflect Improved Price Attractiveness

As of 23 Jul 2026, Borosil Scientific Ltd trades at ₹156.55, down 2.82% from the previous close of ₹161.10. The stock’s 52-week range spans ₹96.65 to ₹187.30, indicating a recovery from lows but still below its recent peak. The company’s price-to-earnings (P/E) ratio stands at 32.65, a figure that has recently been reclassified from expensive to fair valuation territory by MarketsMOJO’s grading system. This reclassification is significant given the company’s prior Hold rating, which has now been upgraded to Buy as of 14 Jul 2026, reflecting improved investor sentiment.

Alongside the P/E ratio, the price-to-book value (P/BV) is at 3.15, which aligns with a fair valuation stance when compared to peers. The enterprise value to EBITDA (EV/EBITDA) ratio is 20.29, slightly higher than some competitors but still within a reasonable range for the industrial products sector. The PEG ratio of 1.07 suggests that the stock’s price growth is broadly in line with its earnings growth, supporting the fair valuation assessment.

Peer Comparison Highlights Relative Valuation

When compared with key industry peers, Borosil Scientific’s valuation metrics present a balanced picture. Saint-Gobain Sekurit, a major competitor, is rated as very expensive with a P/E of 25.95 and EV/EBITDA of 19.25, while Haldyn Glass and Empire Industries are classified as very attractive, with P/E ratios of 25.21 and 11.92 respectively, and EV/EBITDA multiples significantly lower at 12.23 and 7.73. This contrast underscores Borosil Scientific’s position in the mid-range of valuation attractiveness within its sector.

Other peers such as Jai Mata Glass, FGP, and Triveni Glass are marked as risky due to loss-making operations or extreme valuation metrics, further highlighting Borosil Scientific’s relative stability and improving fundamentals.

Financial Performance and Returns Contextualise Valuation

Borosil Scientific’s return on capital employed (ROCE) is a healthy 13.69%, while return on equity (ROE) stands at 9.64%. These figures indicate efficient capital utilisation and moderate profitability, supporting the fair valuation grade. The absence of a dividend yield suggests reinvestment of earnings into growth initiatives, typical for a micro-cap industrial products company.

Examining stock returns relative to the Sensex reveals mixed performance. Year-to-date, Borosil Scientific has delivered a robust 30.4% return, significantly outperforming the Sensex’s negative 9.93% return over the same period. However, over the past year, the stock has declined 12.54%, underperforming the Sensex’s 6.61% loss. This volatility reflects sector-specific challenges and broader market dynamics impacting industrial product stocks.

Valuation Trends and Market Sentiment

The shift from an expensive to a fair valuation grade is a pivotal development. It suggests that the market has recalibrated expectations for Borosil Scientific’s growth prospects and risk profile. The current P/E of 32.65, while still elevated compared to some peers, is more justified by the company’s earnings growth potential and operational metrics than before. The PEG ratio near 1.07 further confirms that the stock price is reasonably aligned with earnings growth forecasts.

Investors should note that the company remains classified as a micro-cap, which inherently carries higher volatility and liquidity risk. The recent downgrade in share price by nearly 3% on the day of reporting reflects short-term profit-taking or sector rotation rather than a fundamental deterioration.

Investment Outlook and Considerations

With the upgrade to a Buy rating and a Mojo Score of 74.0, Borosil Scientific Ltd presents an appealing opportunity for investors seeking exposure to the industrial products sector at a fair valuation. The company’s valuation metrics, while not the cheapest in the peer group, reflect a balanced risk-return profile supported by solid operational returns and a positive earnings trajectory.

However, investors should remain mindful of the stock’s micro-cap status, which can lead to heightened price swings and lower liquidity. The absence of dividend payouts may also deter income-focused investors, although it aligns with growth-oriented capital allocation strategies.

Comparatively, peers such as Haldyn Glass and Empire Industries offer more attractive valuation multiples but may differ in growth prospects and financial stability. Borosil Scientific’s relative outperformance year-to-date versus the Sensex underscores its potential to deliver alpha in a challenging market environment.

Conclusion

Borosil Scientific Ltd’s recent valuation re-rating from expensive to fair, coupled with an upgrade to a Buy rating, signals a renewed price attractiveness for investors. The company’s P/E ratio of 32.65 and P/BV of 3.15 position it favourably within its peer group, supported by solid ROCE and ROE metrics. While short-term price fluctuations persist, the stock’s year-to-date outperformance and reasonable PEG ratio suggest a balanced growth outlook. Investors considering exposure to the industrial products sector should weigh Borosil Scientific’s improved valuation and operational fundamentals against its micro-cap risks and sector dynamics.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today